Due to advances in modern tumor treatments, patients can survive long-term. However, cardiotoxicity caused by tumor therapy poses a significant challenge to both physicians and patients. Early detection and accurate assessment of cardiovascular toxicity from tumor therapy are crucial for guiding clinical treatment and improving patient prognosis. A noninvasive myocardial workup can monitor and assess the development of tumor chemotherapy-related cardiotoxicity. In monitoring oncology chemotherapy-related cardiac injury, a significant decrease in left ventricular ejection fraction (LVEF) of left ventricular systolic function (LVSCF) often indicates severe cardiac injury, making it challenging to monitor early cardiac injury. 3D-STI (three-dimensional speckle tracking imaging) can evaluate early cardiac injury, but its load dependence reduces the accuracy of myocardial function evaluation. In contrast, the noninvasive evaluation of myocardial work using left ventricular pressure-strain loops (PSL), which considers both myocardial deformation and left ventricular pressure, avoids the effect of load dependence on myocardial contractile function and improves the accuracy of myocardial function evaluation. This article reviews the noninvasive evaluation of myocardial work to assess cardiotoxicity associated with tumor chemotherapy.
References
[1]
Dobson, R., Ghosh, A.K., Ky, B., Marwick, T., Stout, M., Harkness, A., et al. (2021) BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines And/or Trastuzumab. JACC: CardioOncology, 3, 1-16. https://doi.org/10.1016/j.jaccao.2021.01.011
[2]
Santoro, C., Arpino, G., Esposito, R., Lembo, M., Paciolla, I., Cardalesi, C., et al. (2017) 2D and 3D Strain for Detection of Subclinical Anthracycline Cardiotoxicity in Breast Cancer Patients: A Balance with Feasibility. European Heart Journal—Cardiovascular Imaging, 18, 930-936. https://doi.org/10.1093/ehjci/jex033
[3]
Lyon, A.R., López-Fernández, T., Couch, L.S., Asteggiano, R., et al. (2022) 2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society. International Cardio-Oncology Society (IC-OS). European Heart Journal, 43, 4229-4361.
[4]
Ky, B., Vejpongsa, P., Yeh, E.T.H., Force, T. and Moslehi, J.J. (2013) Emerging Paradigms in Cardiomyopathies Associated with Cancer Therapies. Circulation Research, 113, 754-764. https://doi.org/10.1161/circresaha.113.300218
[5]
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L., Lyu, Y.L., Liu, L.F., et al. (2012) Identification of the Molecular Basis of Doxorubicin-Induced Cardiotoxicity. Nature Medicine, 18, 1639-1642. https://doi.org/10.1038/nm.2919
[6]
Todorova, V.K., Wei, J.Y. and Makhoul, I. (2021) Subclinical Doxorubicin-Induced Cardiotoxicity Update: Role of Neutrophils and Endothelium. American Journal of Cancer Research, 11, 4070-4091.
[7]
Lyon, A.R., López-Fernández, T., et al. (2022) 2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the Task Force on Cardio-Oncology of the European Society of Cardiology (ESC). European Heart Journal, 43, 4229-4361. https://doi.org/10.1093/eurheartj/ehad196
[8]
Yin, G., Cui, C., An, J., Zhao, K., Yang, K., Li, S., et al. (2022) Assessment of Left Ventricular Systolic Function by Cardiovascular Magnetic Resonance Compressed Sensing Real-Time Cine Imaging Combined with Area-Length Method in Normal Sinus Rhythm and Atrial Fibrillation. Frontiers in Cardiovascular Medicine, 9, Article 896816. https://doi.org/10.3389/fcvm.2022.896816
[9]
Lunning, M.A., Kutty, S., Rome, E.T., Li, L., Padiyath, A., Loberiza, F., et al. (2015) Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium after Doxorubicin-Based Chemotherapy. American Journal of Clinical Oncology, 38, 377-381. https://doi.org/10.1097/coc.0b013e31829e19be
[10]
Ylänen, K., Poutanen, T., Savikurki-Heikkilä, P., Rinta-Kiikka, I., Eerola, A. and Vettenranta, K. (2013) Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines among Long-Term Survivors of Childhood Cancer. Journal of the American College of Cardiology, 61, 1539-1547. https://doi.org/10.1016/j.jacc.2013.01.019
[11]
Wadhwa, D., Fallah-Rad, N., Grenier, D., Krahn, M., Fang, T., Ahmadie, R., et al. (2008) Trastuzumab Mediated Cardiotoxicity in the Setting of Adjuvant Chemotherapy for Breast Cancer: A Retrospective Study. Breast Cancer Research and Treatment, 117, 357-364. https://doi.org/10.1007/s10549-008-0260-6
[12]
Stoodley, P.W., Richards, D.A.B., Hui, R., Boyd, A., Harnett, P.R., Meikle, S.R., et al. (2011) Two-Dimensional Myocardial Strain Imaging Detects Changes in Left Ventricular Systolic Function Immediately after Anthracycline Chemotherapy. European Journal of Echocardiography, 12, 945-952. https://doi.org/10.1093/ejechocard/jer187
[13]
Song, H.N., Qin, Z.Y., Zhou, Q., et al. (2015) Application of Three-Dimensional Speckle Tracking Technology to Construct a Multiparameter Diagnostic Model to Improve the Efficiency of Early Diagnosis of Coronary Artery Stenosis. Chinese Journal of Ultrasound Imaging, 24, Article No. 10.
[14]
Han, M.X., Li, Z., Zhang, Q.L., et al. (2024) Left Ventricular Strain after Anthracycline Chemotherapy with Different Doses of Anthracyclines Assessed by Three-Dimensional Speckle Tracking Imaging. China Clinical Medicine, 31, 559-564.
[15]
Plana, J.C., Galderisi, M., Barac, A., Ewer, M.S., Ky, B., Scherrer-Crosbie, M., et al. (2014) Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 27, 911-939. https://doi.org/10.1016/j.echo.2014.07.012
[16]
Chen, T.Q., Fu, S.P., Ruan, H.D., et al. (2021) Three-Dimensional Speckle Tracking Imaging Combined with Myocardial Work to Evaluate the Effect of Anthracyclines on Left Ventricular Function in Breast Cancer Patients. Chinese Journal of Ultrasound Medicine, 37, 539-542.
[17]
Ke, Q., Xu, H., Bai, J., Xiong, L. and Li, M. (2020) Evaluation of Global and Regional Left Ventricular Myocardial Work by Echocardiography in Patients with Chronic Kidney Disease. Echocardiography, 37, 1784-1791. https://doi.org/10.1111/echo.14864
[18]
Galli, E., Vitel, E., Schnell, F., Le Rolle, V., Hubert, A., Lederlin, M., et al. (2018) Myocardial Constructive Work Is Impaired in Hypertrophic Cardiomyopathy and Predicts Left Ventricular Fibrosis. Echocardiography, 36, 74-82. https://doi.org/10.1111/echo.14210
[19]
Liu, X., Jiang, F., Zhong, X.Q., et al. (2020) The Value of Serum sST-2 and Galectin-3 in Monitoring Cardiotoxicity of Paclitaxel Combined with Platinum-Based Chemotherapy. Journal of Practical Cancer, 35, 2080-2084.
[20]
Deng, J.-H., Deng, J., et al. (2015) Clinical Outcome of Cisplatin-Based Chemotherapy Is Associated with the Polymorphisms of GSTP1 and XRCC1 in Advanced Non-Small Cell Lung Cancer Patients. Clinical and Translational Oncology, 17, 720-726. https://doi.org/10.1007/s12094-015-1299-6
[21]
Liao, Y.Y., You, Y.G., et al. (2023) Clinical Significance of Left Ventricular Stress-Strain Loop Technique in Assessing Left Ventricular Myocardial Function in Nasopharyngeal Carcinoma Chemotherapy Patients. Chinese Journal of Modern Medicine, 33, 79-85.
[22]
Papadopoulos, K., Özden Tok, Ö., Mitrousi, K. and Ikonomidis, I. (2021) Myocardial Work: Methodology and Clinical Applications. Diagnostics, 11, Article 573. https://doi.org/10.3390/diagnostics11030573
[23]
Galli, E., John-Matthwes, B., Rousseau, C., Schnell, F., Leclercq, C. and Donal, E. (2019) Echocardiographic Reference Ranges for Myocardial Work in Healthy Subjects: A Preliminary Study. Echocardiography, 36, 1814-1824. https://doi.org/10.1111/echo.14494
[24]
Jia, X.H., Kang, C.M., Shen, Y.M., et al. (2024) Changes in Local Myocardial Function after Chemotherapy in Breast Cancer Patients Evaluated by Ultrasound Myocardial Performance. Clinical Medicine Research and Practice, 9, 14-18.
[25]
Jaber, M., Armand, A., Rochette, E., Monzy, S., Greze, V., Kanold, J., et al. (2024) Anthracycline-Induced Cardiotoxicity on Regional Myocardial Work and Left Ventricular Mechanical Dispersion in Adolescents and Young Adults in Post-Lymphoma Remission. Cancer Medicine, 13, e6857. https://doi.org/10.1002/cam4.6857
[26]
Liu, F.Q., Ren, J.L. and Wang, Z.G. (2015) Research Progress of Echocardiographic Assessment of Cardiac Function in Patients with Metabolic Syndrome. Chinese Journal of Medical Imaging, 23, 790-793.
[27]
Russell, K., Eriksen, M., Aaberge, L., Wilhelmsen, N., Skulstad, H., Gjesdal, O., et al. (2013) Assessment of Wasted Myocardial Work: A Novel Method to Quantify Energy Loss Due to Uncoordinated Left Ventricular Contractions. American Journal of Physiology-Heart and Circulatory Physiology, 305, H996-H1003. https://doi.org/10.1152/ajpheart.00191.2013
[28]
Moya, A., Buytaert, D., Beles, M., Paolisso, P., Duchenne, J., Huygh, G., et al. (2023) Serial Non-Invasive Myocardial Work Measurements for Patient Risk Stratification and Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients: A Single-Centre Observational Study. Journal of Clinical Medicine, 12, Article 1652. https://doi.org/10.3390/jcm12041652
[29]
Roemer, S., Jaglan, A., Santos, D., Umland, M., Jain, R., Tajik, A.J., et al. (2021) The Utility of Myocardial Work in Clinical Practice. Journal of the American Society of Echocardiography, 34, 807-818. https://doi.org/10.1016/j.echo.2021.04.013
[30]
Donal, E., Galli, E., Hubert, A. and Bouzille, G. (2017) New Indices of Left Ventricular Function: Let’s Move from Ejection Fraction to More Physiological Parameters. The Journal of Physiology, 595, 3959-3960. https://doi.org/10.1113/jp274108
